MISCH Hub targets nutrition: New study to uncover protein’s impact on critically ill patients
MISCH hub academics, Dr Sophie Zaloumis, Prof Adam Deane, A/Prof An Tran-Duy, and A/Prof Emily Karahalios are co-authors on a new publication for the TARGET Protein trial.
The new publication details the statistical analysis plan for the TARGET Protein trial, a cluster randomized, cross‑sectional, double cross‑over, open‑label, registry‑embedded, pragmatic clinical trial conducted across Australia and New Zealand.
This trial investigates the impact of augmented enteral protein administration on clinical outcomes in critically ill adults. By analyzing key patient data, the study aims to determine whether increased protein intake can improve recovery and survival rates in intensive care settings.
The findings could help refine nutritional strategies for critically ill patients, potentially transforming standard care practices.